Reporter Gene Assay Market Expected to Achieve 8.9% CAGR by 2029: Growth Forecast Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Reporter Gene Assay Market Size By 2025?
The market size of the reporter gene assay has exhibited significant growth in the past few years. It is projected to expand from $6.39 billion in 2024 to $6.99 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%. The previous growth can be associated with the escalating demand for cell-based assays, augmenting genomics research activities, an upsurge in drug discovery and development research, growing need for personalized treatments, and the increasing demand for early diagnosis.

How Big Is the Reporter Gene Assay Market Size Expected to Grow by 2029?
Significant expansion is anticipated in the reporter gene assay market in the coming years, with predictions suggesting it will reach $9.84 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.9%. Factors contributing to this predicted growth during the forecast period include increasing occurrences of chronic genetic diseases, a surge in the demand for customised medicine, growth in the usage of molecular imaging systems, widening of gene therapy practices, and governmental support. The forecast period will also witness major trends, such as enhancement in gene therapy technology, progress in molecular biology, demand for superior molecular diagnostic instruments, a shift towards 3d cellular culture models, and key strategic collaborations.

View the full report here:
https://www.thebusinessresearchcompany.com/report/reporter-gene-assay-global-market-report

Which Key Market Drivers Powering Reporter Gene Assay Market Expansion and Growth?
The expansion of the reporter gene assay market is likely to be fueled by rising drug discovery and development research. This research pertains to the organised process across the medical, biotech and pharmacology sectors that culminates in the identification, production and introduction of fresh therapeutics to the market. The boost in drug discovery and development research can be attributed to progress in proteomics, high-throughput screening, genomics, and the triumphant development and validation of novel drugs. Reporter gene assays are instrumental in this research, providing researchers with insights into gene regulation, identifying potential drug targets, screening compound libraries, and testing the effectiveness and safety of potential drugs. For example, the National Science Foundation, a government agency in the US, reported in May 2024 that the country undertook roughly $885.6 billion worth of research and development (R&D) in 2022. This represented a 12% increase from the previous year in nominal dollars and a 5% hike when accounting for inflation. Hence, the surge in drug discovery and development research is steering the growth of the reporter gene assay market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16526&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Reporter Gene Assay Market?
Leading firms in the reporter gene assay market are concentrating on creating novel solutions such as ultrasensitive multiplexed digital PCR assays in order to fortify their market standing. These assays accurately identify and determine the quantity of nucleic acids by dividing the sample into thousands or even millions of small reactions, each containing tiny concentrations of target DNA or RNA molecules. In April 2024, for example, Bio-Rad Laboratories Inc., a life science research company based in the US, introduced the ddPLEX ESR1 Mutation Detection Kit, which is the first of its kind to use an ultrasensitive multiplexed digital PCR assay. The newly introduced assay, ideal for detecting minute mutations in breast cancer, excels in sensitivity and allows for early and accurate disease tracking in complex samples. Its multiplexing capability makes it possible to detect several mutations simultaneously, simplifying the testing process. This revolutionary assay could potentially transform research in breast cancer and strategies for personal treatment.

What Are the Emerging Segments in the Reporter Gene Assay Market?
The reporter gene assay market covered in this report is segmented -

1) By Product: Assay Kits, Reagents
2) By Application: Promoter Structural And Functional Analysis, Cell Signaling Pathways, Protein Interaction, Clinical And Gene Regulation
3) By End-User: Biotechnology And Pharmaceutical Companies, Research And Academic Institutes, Hospital And Diagnostic Laboratories, Contract Research Organizations

Subsegments:
1) By Assay Kits: Luciferase Reporter Assay Kits, ß-galactosidase Reporter Assay Kits, Fluorescent Reporter Assay Kits, Secreted Alkaline Phosphatase (SEAP) Assay Kits
2) By Reagents: Luciferase Substrates, ß-galactosidase Substrates, Fluorescent Proteins, Detection Buffers And Enhancers

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16526&type=smp

Who Are the Global Leaders in the Reporter Gene Assay Market?
Major companies operating in the reporter gene assay market are Roche Diagnostics, Thermo Fisher Scientific, Danaher Corporation, Merck KGaA, Becton Dickinson and Company (BD Biosciences), GE Healthcare, Lonza Group, Agilent Technologies, Sartorius AG, PerkinElmer Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., GenScript Biotech Corporation, Abcam plc, Promega Corporation, Promega Corporation, Takara Bio Inc., New England Biolabs (NEB), OriGene Technologies Inc., Cell Signaling Technology Inc., SABiosciences, Enzo Biochem Inc., InvivoGen, Biotium Inc., Enzo Life Sciences Inc., BioAssay Systems, Indigo Biosciences Inc.

Which are the Top Profitable Regional Markets for the Reporter Gene Assay Industry?
North America was the largest region in the reporter gene assay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the reporter gene assay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16526

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.